Cancer-associated fibroblast–secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas
Open Access
- 19 December 2023
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (4)
Abstract
A recently published JCI paper revealed that cancer-associated fibroblasts (CAFs) are present in glioblastoma and are defined by the presence of 9 transcriptional markers (1). CAFs can form a barrier around cancer cells that prevents their detection by T cells (2). The normal brain has low levels of collagen, but deposition increases in gliomas, especially around vessels. In addition to collagen facilitating tumor invasion and providing a niche for cancer stem cells, collagen has also been shown to trigger immune suppression through LAIR1-mediated T cell exhaustion and alternative activation of macrophages (3, 4). CAFs were identified from single cells isolated from 21 samples (high-grade gliomas [HGGs], 5; pilocytic astrocytomas [PAs], 13; and normal brains [NBs], 3) by examining differential expressed genes against known CAF markers and CAF subtype markers (Figure 1A). The percentage of CAFs was a function of glioma grade, with 1% CAFs present in NBs/low-grade gliomas and nearly 20% in HGGs with an enrichment of the immunomodulatory CAF subtype (Figure 1, B and C). Gene ontology analysis suggested CAF-mediated immune suppression and migration inhibition (Figure 1D). To ascertain the collagen types produced by CAFs, scRNA-Seq data from our pediatric glioma cohort complemented with public adult glioblastoma data sets (5) were analyzed and showed that CAFs expressed COL6A1/A2 > COL4A1, COL9A3, COL12A1 > COL1A (Figure 1E and Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/ JCI176613DS1). ELISA confirmed collagen production by human glioblastoma CAFs at 773 μg/mL. Within the public data set (5), the CAF populations are included in the pericyte compartment. Pericytes expressed the greatest diversity of collagen subtypes and were the main source of COL1A1/A2, COL3A1, COL4A1/A2, COL5A1/A2, COL6A1/A2/A3, and COL18A1; endothelial cells were also a source of COL4A1/A2 and COL18A1. Glioma cells expressed modest levels of COL6A1 and COL9A3 (Supplemental Figure 1A). Prognostic analysis of collagen subtypes from The Cancer Genome Atlas revealed that 6 types were negatively associated with outcome, including COL1A2 (high vs. low expression, 12.3 vs. 16.1 months; HR = 0.68; P = 0.03); COL6A1 (11.9 vs. 15.9 months; HR = 0.53; P = <0.01); COL8A2 (12.6 vs. 15 months; HR = 0.65; P = 0.02); COL22A1 (11.8 vs. 15.4 months; HR = 0.67; P = 0.03); COL24A1 (11.8 vs. 15 months; HR = 0.64; P = 0.01); and COL27A1 (11.8 vs. 15.8 months; HR = 0.63; P = 0.01) (Supplemental Figure 1B). Among the most frequently expressed and prognostic collagens, COL1A2, COL4A1, and COL6A1 were enriched near the hyperplastic vessels and microvascular proliferation, whereas COL1A2 and COL4A1 were enriched in the perinecrotic regions (Supplemental Figure 1C). To validate these findings, multiplex imaging demonstrated that CAFs were embedded in COL6A1/A2 within HGGs (Figure 1F and Supplemental Video 1). COL1A and COL4A were expressed in tumor glomeruloid strucKeywords
Funding Information
- National Cancer Institute (CA120813,NS120547,CA22174,, CA060553)
- Lou and Jean Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center (N/A)
- Mosky family (N/A)
- Stephen Coffman Trust (N/A)
This publication has 5 references indexed in Scilit:
- Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effectsJournal of Clinical Investigation, 2023
- Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung TumorsCancer Discovery, 2022
- Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy targetNature Communications, 2022
- Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1OncoImmunology, 2020
- Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1Journal of Experimental Medicine, 2006